Difficult-to-treat RA calls for reassessments of medication, diagnosis
Physicians should confront difficult-to-treat rheumatoid arthritis by rethinking the diagnosis, reassessing available medications, and — importantly — talking with the patient, according to a speaker at the 2020 Congress of Clinical Rheumatology-West. A EULAR recommendation, published Sept. 30, provided the following three criteria for difficult-to-treat RA: